# Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.

> **NCT05817851** · PHASE2 · RECRUITING · sponsor: **Centre Hospitalier de Bethune** · enrollment: 234 (estimated)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)
- **DRUG:** standard treatment

## Key facts

- **NCT ID:** NCT05817851
- **Lead sponsor:** Centre Hospitalier de Bethune
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-27
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-01-24
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05817851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05817851, "Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05817851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*